CVS CEO Larry Merlo told analysts and stockholders Tuesday CVS would lose many of its prescriptions due to deals pharmacy competitor Walgreens signed with large health benefits plans like Prime Therapeutics.
“Very recent pharmacy network changes in the marketplace are expected to cause some retail prescriptions to begin migrating out of our pharmacies this quarter,” Mr. Merlo said, according to Forbes.
More articles on finance issues:
Mistaken identification by Florida hospital lands wrong man with $5k medical bill
3-year sentence for father who faked $140k in kids’ medical bills
Decatur Memorial facility fee draws patient fire after implementation
